| Q36156581 | A possible role for inflammation in mediating apoptosis of oligodendrocytes as induced by the Lyme disease spirochete Borrelia burgdorferi. |
| Q34098780 | A preliminary study of neck-stomach syndrome |
| Q36269307 | A sublethal dose of TNFalpha potentiates kainate-induced excitotoxicity in optic nerve oligodendrocytes. |
| Q28389765 | AMPA-Kainate Receptor Inhibition Promotes Neurologic Recovery in Premature Rabbits with Intraventricular Hemorrhage |
| Q52348482 | Adenosine A2A Receptor Signaling in the Immunopathogenesis of Experimental Autoimmune Encephalomyelitis. |
| Q103034460 | Altered astrocytic function in experimental neuroinflammation and multiple sclerosis |
| Q36718656 | Astrocytes Regulate GLP-1 Receptor-Mediated Effects on Energy Balance. |
| Q36657652 | Autoimmune modulation of astrocyte-mediated homeostasis. |
| Q38957246 | Biochemical, cell biological, pathological, and therapeutic aspects of Krabbe's disease |
| Q39669812 | Body Cooling Ameliorating Spinal Cord Injury May Be Neurogenesis-, Anti-inflammation- and Angiogenesis-Associated in Rats |
| Q44939798 | Brain injury induced by intracerebral injection of interleukin-1beta and tumor necrosis factor-alpha in the neonatal rat. |
| Q36949750 | CB2 cannabinoid receptors as an emerging target for demyelinating diseases: from neuroimmune interactions to cell replacement strategies |
| Q33623734 | CXCR2 signaling protects oligodendrocytes and restricts demyelination in a mouse model of viral-induced demyelination |
| Q64916145 | Caspase-1 inhibition prevents glial inflammasome activation and pyroptosis in models of multiple sclerosis. |
| Q93013739 | Current Agents and Related Therapeutic Targets for Inflammation After Acute Traumatic Spinal Cord Injury |
| Q52143402 | Cytokine Profile in Patients with Progressive Multiple Sclerosis and Its Association with Disease Progression and Disability. |
| Q26740237 | Cytokine and Growth Factor Activation In Vivo and In Vitro after Spinal Cord Injury |
| Q21284848 | Cytokines and chemokines at the crossroads of neuroinflammation, neurodegeneration, and neuropathic pain |
| Q47182276 | Decrease in Cavity Size and Oligodendrocyte Cell Death Using Neurosphere-Derived Oligodendrocyte-Like Cells in Spinal Cord Contusion Model |
| Q36090107 | Demyelination as a rational therapeutic target for ischemic or traumatic brain injury |
| Q48536700 | Development of microglia in the cerebral white matter of the human fetus and infant |
| Q41825402 | Differential effects of Th1, monocyte/macrophage and Th2 cytokine mixtures on early gene expression for glial and neural-related molecules in central nervous system mixed glial cell cultures: neurotrophins, growth factors and structural proteins |
| Q51586474 | Differential effects of Th1, monocyte/macrophage and Th2 cytokine mixtures on early gene expression for immune-related molecules by central nervous system mixed glial cell cultures. |
| Q37091141 | Differential effects of Th1, monocyte/macrophage and Th2 cytokine mixtures on early gene expression for molecules associated with metabolism, signaling and regulation in central nervous system mixed glial cell cultures |
| Q35709144 | Differential expression of sPLA2 following spinal cord injury and a functional role for sPLA2-IIA in mediating oligodendrocyte death |
| Q38858026 | Evidence for an immune signature of prenatal alcohol exposure in female rats |
| Q36822954 | Excitotoxic damage to white matter. |
| Q46488778 | Excitotoxic oligodendrocyte death and axonal damage induced by glutamate transporter inhibition |
| Q34487007 | Exercise preconditioning protects against spinal cord injury in rats by upregulating neuronal and astroglial heat shock protein 72. |
| Q37691262 | Experimental models for analysis of oligodendrocyte pathophysiology in stroke |
| Q36465598 | Finding disease candidate genes by liquid association |
| Q38366783 | From demyelination to remyelination: the road toward therapies for spinal cord injury |
| Q90345195 | Glial Cells: Role of the Immune Response in Ischemic Stroke |
| Q46097376 | GluR2-free alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptors intensify demyelination in experimental autoimmune encephalomyelitis |
| Q48858248 | Glutamate excitotoxicity in the cerebellum mediated by IL-1β. |
| Q21284455 | Glutamate receptors in neuroinflammatory demyelinating disease |
| Q36277315 | Glutamate-mediated glial injury: mechanisms and clinical importance |
| Q34500255 | Granulocyte colony-stimulating factor (G-CSF) protects oligodendrocyte and promotes hindlimb functional recovery after spinal cord injury in rats |
| Q48325544 | High-mobility group box-1 as an autocrine trophic factor in white matter stroke |
| Q40510056 | Human endogenous retrovirus glycoprotein-mediated induction of redox reactants causes oligodendrocyte death and demyelination |
| Q33691302 | Human umbilical cord blood cells decrease microglial survival in vitro |
| Q47852970 | Inflammasome in drug abuse |
| Q36896275 | Inflammation and its role in neuroprotection, axonal regeneration and functional recovery after spinal cord injury |
| Q38954648 | Inflammation, Glutamate, and Glia: A Trio of Trouble in Mood Disorders |
| Q36943086 | Interaction of the Lyme disease spirochete Borrelia burgdorferi with brain parenchyma elicits inflammatory mediators from glial cells as well as glial and neuronal apoptosis |
| Q92633176 | Interleukin-1 Beta Neutralization Attenuates Traumatic Brain Injury-Induced Microglia Activation and Neuronal Changes in the Globus Pallidus |
| Q28572380 | Interleukin-1 beta induction of neuron apoptosis depends on p38 mitogen-activated protein kinase activity after spinal cord injury |
| Q37100241 | Interleukin-1beta: a bridge between inflammation and excitotoxicity? |
| Q47987358 | Interleukin-1β alters glutamate transmission at purkinje cell synapses in a mouse model of multiple sclerosis. |
| Q35078252 | Interleukin-1β and interleukin-1 receptor antagonist appear in grey matter additionally to white matter lesions during experimental multiple sclerosis |
| Q41043799 | Mechanisms underlying the promotion of functional recovery by deferoxamine after spinal cord injury in rats |
| Q81034804 | Microglia |
| Q39360213 | Microglial SK3 and SK4 currents and activation state are modulated by the neuroprotective drug, riluzole |
| Q44477698 | Multiple sclerosis lymphocytes upregulate A2A adenosine receptors that are antiinflammatory when stimulated |
| Q26797407 | Myelin damage and repair in pathologic CNS: challenges and prospects |
| Q45394547 | Myelin-induced microglial neurotoxicity can be controlled by microglial metabotropic glutamate receptors. |
| Q48215785 | Neuregulin-1 positively modulates glial response and improves neurological recovery following traumatic spinal cord injury. |
| Q37755972 | Neurobiology of injury to the developing brain |
| Q28388537 | Neuroinflammation in the normal aging hippocampus |
| Q37462628 | Neuroprotective effect of oligodendrocyte precursor cell transplantation in a long-term model of periventricular leukomalacia |
| Q84080843 | Neuroprotective role of fibroblast growth factor-2 in experimental autoimmune encephalomyelitis |
| Q52310773 | Neutralization of Interleukin-1β following Diffuse Traumatic Brain Injury in the Mouse attenuates the loss of Mature Oligodendrocytes. |
| Q41165010 | Newer insights to pathogenesis of traumatic brain injury. |
| Q26741723 | Oligodendrocyte Injury and Pathogenesis of HIV-1-Associated Neurocognitive Disorders |
| Q35006477 | Oligodendrocyte fate after spinal cord injury |
| Q38202292 | Oligodendrocyte pathophysiology and treatment strategies in cerebral ischemia |
| Q30405077 | Oligodendroglial alterations and the role of microglia in white matter injury: relevance to schizophrenia |
| Q28486241 | Oxidative stress and proinflammatory cytokines contribute to demyelination and axonal damage in a cerebellar culture model of neuroinflammation |
| Q39929858 | PPARalpha ligands inhibit radiation-induced microglial inflammatory responses by negatively regulating NF-kappaB and AP-1 pathways |
| Q36941006 | Pathogenesis of cerebral white matter injury of prematurity |
| Q52646465 | Perturbing chondroitin sulfate proteoglycan signaling through LAR and PTPσ receptors promotes a beneficial inflammatory response following spinal cord injury. |
| Q40462711 | Pituitary adenylate cyclase-activating polypeptide (PACAP) ameliorates experimental autoimmune encephalomyelitis by suppressing the functions of antigen presenting cells. |
| Q33846630 | Protease-activated receptor-1 activation by granzyme B causes neurotoxicity that is augmented by interleukin-1β |
| Q30579142 | Rapid inflammasome activation in microglia contributes to brain disease in HIV/AIDS |
| Q33998381 | Reduced extracellular zinc levels facilitate glutamate-mediated oligodendrocyte death after trauma |
| Q37356420 | Role of PPARs in Radiation-Induced Brain Injury |
| Q36370763 | Role of glutamate receptors in periventricular leukomalacia |
| Q36052905 | Stress exacerbates neuron loss and microglia proliferation in a rat model of excitotoxic lower motor neuron injury |
| Q48126920 | Suppressed oligodendrocyte steroidogenesis in multiple sclerosis: Implications for regulation of neuroinflammation |
| Q26768210 | Systematic Review of Pharmacological Properties of the Oligodendrocyte Lineage |
| Q45275684 | Systemic and Local Cytokine Profile following Spinal Cord Injury in Rats: A Multiplex Analysis |
| Q39324087 | The IL-1β phenomena in neuroinflammatory diseases |
| Q53287408 | The Inflammasome Sensor, NLRP3, Regulates CNS Inflammation and Demyelination via Caspase-1 and Interleukin-18 |
| Q34995998 | The developing oligodendrocyte: key cellular target in brain injury in the premature infant |
| Q83410331 | The magnitude of the antigen-specific T cell response is separated from the severity of spinal cord histopathology in remitting-relapsing experimental autoimmune encephalomyelitis |
| Q38231965 | The microanatomy of spinal cord injury: a review. |
| Q33289726 | Therapeutic management of cognitive disorders in multiple sclerosis |
| Q64061191 | Traumatic Spinal Cord Injury: An Overview of Pathophysiology, Models and Acute Injury Mechanisms |
| Q35097752 | Tumor necrosis factor promoter haplotype associated with schizophrenia reveals a linked locus on 1q44. |
| Q35953300 | What do we know about the mechanism of action of disease-modifying treatments in MS? |
| Q36747748 | eIF2B and oligodendrocyte survival: where nature and nurture meet in bipolar disorder and schizophrenia? |